Literature DB >> 27042846

Longer delay of hematological recovery and increased transfusion needs after haploidentical compared to non-haploidentical stem cell transplantation.

A Desjonqueres1,2, M Illiaquer3, A Duquesne4, Y Le Bris1, P Peterlin2, T Guillaume2, J Delaunay2,5, F Rialland6, P Moreau2, M C Béné1, P Chevallier2, M Eveillard1.   

Abstract

Mesh：

Year:  2016        PMID： 27042846     DOI： 10.1038/bmt.2016.80

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  15 in total

Review 1.  Allogeneic transplantation in the UK: an aggregation of marginal gains?

Authors:  Kirsty J Thomson; Karl S Peggs
Journal:  Br J Haematol       Date:  2013-07-27       Impact factor: 6.998

Review 2.  The great debate: haploidentical or cord blood transplant.

Authors:  K K Ballen; T R Spitzer
Journal:  Bone Marrow Transplant       Date:  2010-11-01       Impact factor: 5.483

Review 3.  Hematopoietic stem cell transplantation for non-Hodgkin lymphoma.

Authors:  Vijaya Raj Bhatt; Julie M Vose
Journal:  Hematol Oncol Clin North Am       Date:  2014-09-22       Impact factor: 3.722

Review 4.  Which Patients Should Undergo Allogeneic Stem Cell Transplantation for Myelodysplastic Syndromes, and When Should We Do It?

Authors:  Betul Oran
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2015-06

5.  Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study.

Authors:  Yu Wang; Qi-Fa Liu; Lan-Ping Xu; Kai-Yan Liu; Xiao-Hui Zhang; Xiao Ma; Zhi-Ping Fan; De-Pei Wu; Xiao-Jun Huang
Journal:  Blood       Date:  2015-05-04       Impact factor: 22.113

6.  Allogeneic hematopoietic stem cell transplantation in patients with polycythemia vera or essential thrombocythemia transformed to myelofibrosis or acute myeloid leukemia: a report from the MPN Subcommittee of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation.

Authors:  Federico Lussana; Alessandro Rambaldi; Maria Chiara Finazzi; Anja van Biezen; Marijke Scholten; Elena Oldani; Alessandra Carobbio; Simona Iacobelli; Jurgen Finke; Arnon Nagler; Liisa Volin; Thierry Lamy; Renate Arnold; Mohamad Mohty; Mauricette Michallet; Theo de Witte; Eduardo Olavarria; Nicolaus Kröger
Journal:  Haematologica       Date:  2014-01-03       Impact factor: 9.941

7.  Haploidentical, unmanipulated, G-CSF-primed bone marrow transplantation for patients with high-risk hematologic malignancies.

Authors:  Paolo Di Bartolomeo; Stella Santarone; Gottardo De Angelis; Alessandra Picardi; Laura Cudillo; Raffaella Cerretti; Gaspare Adorno; Stefano Angelini; Marco Andreani; Lidia De Felice; Maria Cristina Rapanotti; Loredana Sarmati; Pasqua Bavaro; Gabriele Papalinetti; Marta Di Nicola; Franco Papola; Mauro Montanari; Arnon Nagler; William Arcese
Journal:  Blood       Date:  2012-11-19       Impact factor: 22.113

8.  Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings.

Authors:  R Szydlo; J M Goldman; J P Klein; R P Gale; R C Ash; F H Bach; B A Bradley; J T Casper; N Flomenberg; J L Gajewski; E Gluckman; P J Henslee-Downey; J M Hows; N Jacobsen; H J Kolb; B Lowenberg; T Masaoka; P A Rowlings; P M Sondel; D W van Bekkum; J J van Rood; M R Vowels; M J Zhang; M M Horowitz
Journal:  J Clin Oncol       Date:  1997-05       Impact factor: 44.544

Review 9.  Which Acute Myeloid Leukemia Patients Should Be Offered Transplantation?

Authors:  Eolia Brissot; Mohamad Mohty
Journal:  Semin Hematol       Date:  2015-03-17       Impact factor: 3.851

Review 10.  Hematopoietic stem cell transplantation donor sources in the 21st century: choosing the ideal donor when a perfect match does not exist.

Authors:  Natasha Kekre; Joseph H Antin
Journal:  Blood       Date:  2014-06-09       Impact factor: 22.113
View more
  1 in total

1.  Impact on early outcomes and immune reconstitution of high-dose post-transplant cyclophosphamide vs anti-thymocyte globulin after reduced intensity conditioning peripheral blood stem cell allogeneic transplantation.

Authors:  Christelle Retière; Catherine Willem; Thierry Guillaume; Henri Vié; Laetitia Gautreau-Rolland; Emmanuel Scotet; Xavier Saulquin; Katia Gagne; Marie C Béné; Berthe-Marie Imbert; Beatrice Clemenceau; Pierre Peterlin; Alice Garnier; Patrice Chevallier
Journal:  Oncotarget       Date:  2018-01-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.